AF with CKD — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Apixaban with dose adjustment per labeling
Apixaban has labeling for use in severe CKD with dose adjustments; dabigatran/rivaroxaban dosing is limited in advanced CKD; aspirin alone is inadequate; anticoagulation is not absolutely contraindicated by CKD alone.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/cardiovascular-conditions